The analysis of larger cohorts of kidney and breast cancers for which clinical follow-up data were available identified significant associations of reduced CK18 immunostaining with unfavorable tumor phenotype and—in case of clear cell renal cell carcinoma—poor patient prognosis. The gene discussed is KRT18; the disease is neoplasm.